CompletedNCT00356278
Virtual-reality exposure with D-cycloserine or placebo for PTSD in veterans
About this title
Read the official source — NCT00356278Medication studyAges 21–65United States
Understand this study
Who was this study for?
Listed age limits: 21 years to 65 years.
- Listed locations
- AtlantaSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateSeptember 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 156
- Sponsor
- Emory University
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT00356278
- Official title
Show the full official title
A Cognitive Enhancer May Facilitate Behavioral Exposure Therapy for Veterans With PTSD
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Atlanta
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Emory University, a university.
Did this study involve medication?
Yes. The study involved medication, including D-Cycloserine, Alprazolam and Placebo.
Who was this study for?
Listed age limits: 21 years to 65 years.
